Here, systemic, or local effects of the Hsp90 inhibitor STA-9090 (Ganetespib), targeting specifically ATP-binding domain of Hsp90, on development of the experimental mouse model of dinitrochlorobenzene (DNCB)-induced AD were studied. The gene discussed is HSP90AB1; the disease is Alzheimer disease.